Thyroid-binding globulin increased

In thyrotoxic Graves disease, there is an increase in the overall hormone production rate with a disproportionate increase in T3 relative to T4 (Table 20-1). Saturation of thyroid-binding globulin is increased due to the elevated levels of serum T4 and T3, which is reflected in an elevated T3 resin uptake. As a result, the concentrations of free T4, free T3, and the free T4 and T3 indices are increased to an even greater extent than are the measured serum total T4 and T3 concentrations. The TSH level is undetectable due to negative feedback by elevated levels of thyroid hormone at the pituitary. In... 

Oral contraceptives have their most significant effect on endocrine parameters. Blood cortisol, thyroxine, protein-bound iodine, T3 uptake, and urinary free cortisol are elevated. Urinary 17,21-dihydroxy steroids, 17-ketosteroids, and estrogens are decreased. There is no effect on urinary catecholamines or VMA (Table 10) (LIO). The effect of thyroid functions tests is due to the administered hormone stimulating an increase in the production of thyroid-binding globulin which in turn binds 1-thyroxine. The lowering of free thyroxine stimulates the anterior pituitary to produce thyrotropin, which in turn stimulates the thyroid to produce more thyroxine. Since the additional thyroxine is bound to the extra protein, there is an equilibrium and the patient remains clinically euthyroid, but the protein-bound iodine and the thyroxine are elevated. 

Hypothyroidism Estrogen administration leads to increased thyroid-binding globulin (TBG) levels. 

Estrogens can induce the synthesis of thyroid-binding globulin, resulting in an increase in bound T4. Thus, the therapeutic efficacy of the thyroid replacement is reduced. 

A wide range of serum thyroid hormones (T4, FT4, T3, reverse triiodothyronine (rT3), thyroxine sulfate (T4S)), TSH and thyroid binding globulin (TBG) were analyzed in our studies T4, but not FT4 levels were indicative of hypothyroxinemia (Williams et at, 2004 Simpson et at, 2005). In 23—27 week gestation infants, T4 serum levels decrease to a nadir at 7 postnatal days and fail to increase in 28—30 week infants. This is in marked contrast to 31—34 and 37—42 week term infants, who show an increase in serum T4 levels at day 7 (Williams et al., 2004 Simpson et at, 2005). 

Thyroid binding globulin Estrogens, pregnancy increases Adrogens, malnutrition decreases... 

Thyroid function tests - Decreased levels of thyroxine-binding globulin, resulting in decreased total T4 serum levels and increased resin uptake of T3 and T4. Free thyroid hormone levels remain unchanged, and there is no... 

Prolonged therapy with methadone causes increases in serum thyroid hormone-binding globulin, triiodothyronine, and thyroxine, as well as albumin, globulin, and prolactin, and these must be monitored (SEDA-15, 71 SEDA-17, 81). 

In fact, despite losses of thyroxin-binding globulin in the urine, proportional to total proteinuria and accompanied by the loss of bound T3 and T4, plasma concentrations of T4, T3, and thyroid stimulating hormone (TSH) are usually normal in nephrotic subjects. Sometimes T3 levels may be lowered and T4 levels slightly elevated with increased reverse T3, with normal TSH levels excluding the diagnosis of hypothyroidism. Hypoalbuminemia is to be taken into consideration also in hypothyroid patients on thyroxine substitution therapy. 

The concentration of free rather than bound thyroxine is considered to be the most accurate assessment of thyroid activity as this is the fraction which can penetrate cell membranes and exert a metabolic effect. Free thyroxine exists in equilibrium with thyroxine bound to globulin, albumin, and prealbumin. Any changes in the concentration of thyroid binding proteins leading to an increase in free hormone. Thyroid binding prealbumin is reduced after all kinds of stress and the reduction is significant within 24 hours. 

Use with tricyclic antidepressants or sympathomimet-ics may increase the effects of these medications or of thyroid USP, possibly leading to coronary insufficiency or cardiac arrhythmias. Use with oral antidiabetic agents or insulin may affect dosage requirements of these agents. Estrogens, which increase serum thyroxine-binding globulin levels, raise thyroid USP requirements. 

---